Harmony Biosciences Holdings, Inc.
HRMY
$34.10
$1.715.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 215.39M | 243.78M | 239.46M | 200.49M | 184.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 215.39M | 243.78M | 239.46M | 200.49M | 184.73M |
| Cost of Revenue | 44.51M | 68.55M | 59.65M | 38.15M | 31.99M |
| Gross Profit | 170.88M | 175.23M | 179.81M | 162.34M | 152.74M |
| SG&A Expenses | 64.20M | 86.74M | 59.36M | 64.00M | 61.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 178.10M | 205.22M | 173.97M | 152.31M | 128.49M |
| Operating Income | 37.29M | 38.56M | 65.49M | 48.18M | 56.25M |
| Income Before Tax | 39.69M | 40.76M | 67.49M | 49.64M | 57.18M |
| Income Tax Expenses | 7.20M | 18.27M | 16.63M | 9.86M | 11.62M |
| Earnings from Continuing Operations | 32.49M | 22.49M | 50.87M | 39.78M | 45.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.49M | 22.49M | 50.87M | 39.78M | 45.56M |
| EBIT | 37.29M | 38.56M | 65.49M | 48.18M | 56.25M |
| EBITDA | 43.26M | 45.99M | 71.46M | 54.15M | 62.21M |
| EPS Basic | 0.56 | 0.39 | 0.88 | 0.69 | 0.80 |
| Normalized Basic EPS | 0.43 | 0.44 | 0.73 | 0.54 | 0.62 |
| EPS Diluted | 0.55 | 0.38 | 0.87 | 0.68 | 0.78 |
| Normalized Diluted EPS | 0.42 | 0.43 | 0.72 | 0.53 | 0.61 |
| Average Basic Shares Outstanding | 57.82M | 57.63M | 57.55M | 57.47M | 57.31M |
| Average Diluted Shares Outstanding | 58.78M | 58.70M | 58.72M | 58.43M | 58.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |